Contract packaging is the utilisation of a contracted business to package products for shipment and sale. Contract packaging firms, known as co-packers or co-packagers, are hired to package, store, and distribute another company's products, such as pharmaceutical units. Within the pharmaceutical sector, contract packaging companies offer diverse services tailored to pharmaceutical packaging needs, including high-volume commercial solutions for primary and secondary packaging. Additionally, they provide ongoing support services throughout the life cycle of drug products. The global pharmaceutical packaging market, estimated at USD 117.23 billion in 2022, is expected to witness further growth.

Packaging holds a pivotal role in the pharmaceutical supply chain by serving multiple functions such as presentation, promotion, identification, information dissemination, compliance, and stability maintenance of drug products. It also ensures protection during distribution, storage, sale, and consumption. While customized packaging services may vary across companies and countries, they share common objectives of ensuring patient safety and drug efficacy throughout the intended shelf life. This includes maintaining uniformity across different production lots, meticulous documentation of materials and processes, control of potential migration of packaging components into the drug, prevention of drug degradation, and ensuring sterility.

Traditionally, the pharmaceutical packaging industry is categorized into three segments: primary, secondary, and tertiary packaging. Primary packaging, also known as sales or consumer packaging, directly interacts with drug products. Therefore, understanding the potential interactions between primary pharmaceutical packaging containers and their contents is crucial. During the primary research and development stage, efforts are made to confirm drug product stability and compatibility to ensure that custom pharmaceutical packaging remains inert and does not alter the chemical composition of the drug.

Secondary pharmaceutical contract packaging services involve packaging that consolidates individual units of primary packaged goods, often assembling them into multipacket units. Unlike primary packaging, secondary packaging is not intended to hold the drugs but to facilitate their delivery in mass quantities to the point of sale or end user.

For Instance,

In February 2021, the big pharmaceutical outsourcing service provider Central Pharma takes over Biotechnica, the biggest seaweed extract manufacturer of UK.
Pharmaceutical Contract Packaging Market Trends
Increasing Demand for Eco-Friendly & Sustainable Products
There is a growing emphasis on eco-friendly and sustainable packaging solutions. The use of recyclable materials and green technologies aligns with global environmental goals and consumer preferences.

Increasing Demand for Outsourcing
More pharmaceutical companies are outsourcing packaging due to cost efficiencies, focus on core competencies, and the need for specialized packaging solutions.

Increasing Popularity of Biopharmaceuticals
As the demand for biopharmaceuticals increases, there is a rising need for specialized packaging solutions to handle biologics, such as temperature-sensitive packaging and unique delivery systems.

Market Consolidation
There is consolidation in the contract packaging industry as larger players seek to broaden their portfolios and capabilities, often acquiring smaller companies to expand globally.

Personalization and Customization
Pharmaceutical companies are seeking more tailored packaging solutions to cater to specific brand identities and consumer demands, leading to innovation in packaging designs and materials.